FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Here Are the States Getting the Biggest Tax Refunds

Mayor Mamdani Says Exodus From New York Is Just Your Imagination

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

Kagan screamed so loudly at liberal ally after Dobbs leak the ‘wall was shaking,’ book claims

2 US Army soldiers in Alaska injured in bear attack during training exercise

Orange Crush festival returns to Tybee Island as police brace for 50,000 partiers after teen takeover, gunfire

UK Is Lost: After Brutal Gang Rape, Cops Turn on Angry Citizens for Refusing to Be Politically Correct About Unthinkable Crime

BBQ lovers beware: Middle East conflict might disrupt your summer plans this year

Watch: Rep. Boebert Planning Motion to Expel Ilhan Omar from Congress Over Alleged Incestuous Marriage – ‘That One’s Mine… I Have Dibs’

Boston mayor denies funding LGBTQ migrant ‘wellness’ perks after program touts up to $500 benefits

White House goes hands-off in Virginia redistricting fight, despite pressure from Speaker Johnson

Dems sidestep past ‘refuse illegal orders’ demands as they challenge Trump’s Iran war authority

Iran could use detained Americans as ‘sweetener’ in nuclear talks, ex-hostage envoy warns

Air Force Academy’s ‘CULEX’ puts thousands of cadets through realistic 24-hour combat simulation

Trump set to read Scripture from the Oval Office during ‘America Reads the Bible’ event starting Sunday

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”